Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PCAR vs MRNA✓SelectedUSD · MRNAPCAR vs MRNA performance historyLatest closeAs of+0.31%11/13
Stock and ETF performance explorer

PCAR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+115.2%
MRNA return
-3.2%
Excess return
+118.5%
Maximum drawdown
-27.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.3%-3.4%+3.8%+0.4%
7D+4.9%-12.1%+17.1%+5.4%
30D-1.4%-1.3%-0.1%-1.5%
3M-18.1%+250.9%-269.1%-25.1%
6M-4.0%+343.0%-347.0%-15.2%
YTD-1.5%+657.4%-658.9%-18.7%
1Y+13.2%+794.9%-781.7%-8.4%
3Y+35.8%+218.1%-182.3%+17.2%
All+115.2%-3.2%+118.5%+89.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling